Detection of chromosomal aberrations in prostate cancer by fluorescence in situ hybridization (FISH).

doi:10.1016/s0302-2838(03)00414-7

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Detection of chromosomal aberrations in prostate cancer by fluorescence in situ hybridization (FISH).

European urology - 1 Dec 2003

Celep Figen, Karagüzel Ahmet, Ozgür Güner K, Yildiz Kadriye

Abstract excerpt

PURPOSE: Fluorescence in situ hybridization (FISH) is a powerful tool for quantitative analysis of chromosomes and genes and can be applied in a variety of specimens, including cell cultures, isolated nuclei from fresh and fixed tissues, and histological tissue sections. For detection of numerical chromosome aberrations, we examined prostatic cancer samples at our department. In addition, we also observed primary...

Topics

Aged
Case-Control Studies
Chromosome Aberrations
Chromosomes
Cohort Studies
Culture Techniques
Genetic Predisposition to Disease
Humans
In Situ Hybridization, Fluorescence
Male
Middle Aged
Prognosis
Prostatic Neoplasms
Risk Assessment
Sensitivity and Specificity

Source

Open in PubMed

Identifiers

PMID: 14644118
DOI: 10.1016/s0302-2838(03)00414-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics